for RSV-TNFR2 mice followed by an increasing trend in macrophage cell counts at day five p.i.
← all excerpts
Selective Blockade of TNFR1 Improves Clinical Disease and Bronchoconstriction in Experimental RSV Infection.
1
—
—
for RSV-TNFR2 mice followed by an increasing trend in macrophage cell counts at day five p.i.